Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection
Patricia Martínez-Martín(Hospital Universitario Infanta Sofía), José Ramón Arribas(Hospital Universitario La Paz), José Ignacio Bernardino(Hospital Universitario La Paz), María Jiménez-González(Hospital Universitario La Paz), Rosa de Miguel Buckley, Berta Rodés(Madrid Health Service), Lucía Gutiérrez-García(Hospital La Paz Institute for Health Research), Rocío Montejano, Pablo Ryan, Alejandro Vidal(Hospital Universitario La Paz), Cristina Marcelo(Hospital Universitario La Paz), Juan Emilio Losa, María del Mar Arcos-Rueda(Hospital Universitario La Paz), Francisco Jurado(IE University), María Lagarde(Instituto de Salud Carlos III), Andrés Esteban-Cantos(Hospital La Paz Institute for Health Research), Alejandro de Gea Grela(Hospital Universitario La Paz), José Sanz, Leire Pérez‐Latorre, Juan Carlos González(Hospital La Paz Institute for Health Research), Vicente Estrada(Instituto de Salud Carlos III)
Cited by 3
Related Papers
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423